LM-24C5 not checked

LaNova Medicines

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
2 active
2 in total
Targets
 

What this is

How it works
How it works isn't classified yet
How it’s given
“Q2W Administered intravenously Drug: Penpulimab Q2W Administered intravenously Drug:Trifluridine and Tipiracil Hydrochloride Tablets BID,Oral Administration Drug:Bevacizumab Injection Q2W Administered intravenously”In the company’s words, NCT07387081 on ClinicalTrials.gov
Tested for
Advanced Solid Tumor Cancer, Advanced Solid Tumor
Main trialPhase 2
“This study is to evaluate the efficacy and safety of the LM-24C5 in combination with other therapies in subjects with CEACAM5-positive advanced solid tumor”In the company’s words, NCT07387081 on ClinicalTrials.gov

Other drugs for Advanced Solid Tumor Cancer

All 2439 drugs for Advanced Solid Tumor Cancer

Coming up1

Changes0

Last 90 days

No changes yet. We started recording changes on 6 Nov 2026.

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 21 May 2028 Phase II Study of LM-24C5
Phase 1/2Recruiting 30 Jun 2026 A Study of LM-24C5 For Advanced Solid Tumors
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow LM-24C5

Following is part of Solo: you see every change to LM-24C5 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in